Post by Biogen on X
Biogen@biogen
X#News: We announced the completion of the acquisition of RayThera Inc. This acquisition marks another step in growing Biogen’s immunology portfolio, adding multiple potential assets for immune-mediated diseases. Read more: t.co
9 likes3 repliesPosted Aug 6, 2026